Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial.
about
Magnetic Nanoparticles in Cancer TheranosticsOverview about the localization of nanoparticles in tissue and cellular context by different imaging techniquesReactive oxygen species-activated nanomaterials as theranostic agentsHyperthermia using nanoparticles--Promises and pitfalls.Magnetic nanoparticles for theragnosticsDrug delivery nanoparticles in skin cancersClinical Translation of Nanomedicine.Recent advances in imaging-guided interventions for prostate cancers.Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.Potential applications and human biosafety of nanomaterials used in nanomedicineNearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermiaNanomedicine--challenge and perspectives.Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation.Magnetite nanoparticles inhibit tumor growth and upregulate the expression of p53/p16 in Ehrlich solid carcinoma bearing miceNanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.Nanoparticle preconditioning for enhanced thermal therapies in cancerDevelopment of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.Magnetic nanoparticles with high specific absorption rate of electromagnetic energy at low field strength for hyperthermia therapyMagnetic nanoparticle biodistribution following intratumoral administration.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.Directional bleb formation in spherical cells under temperature gradient.A Multimodal System with Synergistic Effects of Magneto-Mechanical, Photothermal, Photodynamic and Chemo Therapies of Cancer in Graphene-Quantum Dot-Coated Hollow Magnetic Nanospheres.Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents.Magnetic nanoparticles and nanocomposites for remote controlled therapies.Magnetic nanoparticle hyperthermia enhances radiation therapy: A study in mouse models of human prostate cancerNanoscale materials for hyperthermal theranostics.Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.Current status of antivascular therapy and targeted treatment in the clinic.Detecting and treating cancer with nanotechnology.Biodegradable and Renal Clearable Inorganic Nanoparticles.Assessment of the evolution of cancer treatment therapiesComputational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapy.Optimizing magnetic nanoparticle design for nanothermotherapy.Comparison of microwave and magnetic nanoparticle hyperthermia radiosensitization in murine breast tumors.Iron Oxide Nanocrystals for Magnetic Hyperthermia Applications.Current devices for high-performance whole-body hyperthermia therapy.Magnetic nanoparticle hyperthermia for prostate cancer.Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications.Bioceramics: from bone regeneration to cancer nanomedicine.Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia.
P2860
Q26784379-F8849B7D-5CD5-4BDD-82D7-810E05BC8013Q26853219-E6190922-1EF2-4C29-A8D9-A679D71F8DA1Q26865564-09BA73AA-E1FE-4709-AE0E-87A69C816C41Q28384618-97AFE799-3700-453D-AB7C-B29CE847DC28Q28389421-8C4921B1-1973-4C18-B985-83B62EEF966EQ28390405-B094EA9D-5E8A-4073-9BD3-19A3CB34EE18Q30355939-42EC2FF8-07A6-4425-970A-185E56AE2BA5Q30406157-AC9AFD03-3A50-4B7D-973D-5252C9A2B3CFQ30439353-016AFE3D-9ABA-4566-A60F-02686C6BCFEEQ32944368-AB668ACF-A8D0-49BE-88D6-96CFBF925470Q33862718-A34E077E-03F2-493D-A6AE-D95358D5C8D2Q34247073-7DFC843F-B006-40B4-9971-06B9901E0423Q34263669-CD598FD8-89E3-4C62-99BD-99D13205E7AFQ34465935-93DC6A6D-B372-4867-8845-1236EB10F229Q34766341-A5004F74-94BA-41F5-8488-53CAE1E0AE00Q34987068-15371087-A268-4059-94EE-D0F5D26C1464Q35025058-D9C0E556-B4F2-4D08-9092-61BDEB6FADBCQ35155145-8C676B06-D597-400E-9983-3F39BD19E688Q35171835-9515261A-6701-4563-B297-36439C8974B5Q35625854-FE162EE3-98F5-4CDC-B691-A8636A6062DAQ35705587-6DC5249D-8EEC-4C37-935B-F3B72AC696A9Q35945741-24B7BCE6-F5EB-4189-9CFF-BA79BC0FEF6CQ36242139-C68306A0-51AC-440D-B675-392AC9F8E23CQ36345256-63C2C909-FF61-491D-B60E-25503C73AFEDQ36416400-7C92D607-C54E-4D80-AF13-442C1A70CA09Q36794937-FDDD405D-7CD5-4A7B-B87E-CA2665393CE7Q36988348-B0BD6D43-EC79-44BA-97C4-06BA7FCAE01AQ37063510-61556385-F0B1-4887-97D3-6ACBC448D81FQ37089855-1B901B6C-7A34-4933-9755-66A3FE21445CQ37094877-77286D0D-0248-42E4-AC16-FCE3ADED9912Q37137408-DD1A21BC-CA66-42A5-82E0-42748B97584EQ37172255-FA37809D-D115-4BB0-85F8-835AEC5F4087Q37331799-2CB170D6-A910-4DBA-8266-E7BE1A14B39FQ37423597-2E07CCCE-1A87-4BDD-999E-0B12531F4BB1Q37669146-D502D0AC-CF80-460B-9D1B-1B7819454DFAQ37737340-4E6499C5-D701-46DC-86AD-3FFCDAEC326BQ37775026-ACDA3DA3-B1A8-4E6A-ADD1-3625B8A9B8E5Q37935681-8664AA2B-BA85-4345-819E-8461A49511B2Q37947163-256FAB26-C4DA-40D6-97C6-065FE5A5AE91Q38133825-4955C752-6995-4B86-BD63-32825D55D8A3
P2860
Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Morbidity and quality of life ...... f a prospective phase I trial.
@en
Morbidity and quality of life ...... f a prospective phase I trial.
@nl
type
label
Morbidity and quality of life ...... f a prospective phase I trial.
@en
Morbidity and quality of life ...... f a prospective phase I trial.
@nl
prefLabel
Morbidity and quality of life ...... f a prospective phase I trial.
@en
Morbidity and quality of life ...... f a prospective phase I trial.
@nl
P2093
P2860
P921
P1476
Morbidity and quality of life ...... of a prospective phase I trial
@en
P2093
Johannsen M
Loening SA
Taymoorian K
Waldöfner N
P2860
P304
P356
10.1080/02656730601175479
P577
2007-05-01T00:00:00Z